Comparison of ramosetron and ondansetron for the treatment of established postoperative nausea and vomiting after laparoscopic surgery: a prospective, randomized, double-blinded multicenter trial.

Ther Clin Risk Manag · 2018 · PMC5875401 · PMID 29618928

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

17 Although differences did not reach statistical significance, 53% of patients receiving ramosetron treatment were prevented from further retching or vomiting without secondary rescue antiemetic administration compared to 44% of patients receiving ondansetron treatment.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.